Hazardous And Nonhazardous Drugs - NAPLEX

1. In a hospital pharmacy, a 46-year-old male (76 kg) with Crohn disease is admitted and continues mercaptopurine 50 mg PO daily (hazardous immunosuppressant); current meds include prednisone 20 mg PO daily and pantoprazole 40 mg PO daily; allergy: latex—itching. A technician asks how to dispose of a partially used bottle and contaminated counting liner after a spill of mercaptopurine tablets in the dispensing area. How should this medication be disposed of safely?
   Answer: Place tablets and contaminated materials into a designated hazardous drug waste container per facility policy This question tests the pharmacy safety concept of safe disposal of hazardous drug waste and contaminated materials. Mercaptopurine is a hazardous immunosuppressant, and spills require disposal in designated hazardous waste containers to prevent environmental and occupational exposure. Choice A ensures safe and compliant practice by using proper waste streams, aligning with USP <800> and EPA regulations. Choice B is incorrect as flushing can contaminate water supplies; choice C is suboptimal because alcohol wiping does not neutralize hazards. Choice D is wrong as intact tablets from spills are still hazardous waste. Train staff on spill kits for hazardous drugs. A framework is to categorize waste as trace or bulk hazardous for appropriate disposal methods.
2. In a community pharmacy, a 48-year-old male (95 kg) is prescribed epinephrine auto-injector 0.3 mg for anaphylaxis; current meds include cetirizine 10 mg PO daily PRN; allergy: peanuts—anaphylaxis. He asks where to keep the auto-injector in his car and whether refrigeration is necessary. Which storage condition is required for this medication?
   Answer: Store at controlled room temperature and protect from extreme heat, cold, and light; do not refrigerate or leave in a hot car This question tests the pharmacy safety concept of temperature control for epinephrine auto-injectors. Epinephrine requires room temperature storage, protected from extremes to maintain efficacy. Choice B ensures safe and compliant practice by avoiding refrigeration and heat per labeling. Choice A is incorrect as extremes degrade it; choice C is suboptimal because freezing damages. Choice D is wrong as sunlight causes degradation. Carry in protective cases. A framework is to educate on excursion allowances for emergency drugs.
3. In a hospital ICU, a 71-year-old female (62 kg) is receiving norepinephrine infusion for septic shock; current meds include piperacillin/tazobactam, vancomycin, and propofol; allergy: none known. The pharmacy is preparing norepinephrine in a light-protective bag and the nurse asks why and how it should be stored on the unit. Which storage condition is required for this medication?
   Answer: Protect norepinephrine from light during storage and administration per institutional policy/product labeling This question tests the pharmacy safety concept of light protection during storage and administration of photosensitive medications. Norepinephrine is light-sensitive and requires protection to maintain potency and prevent degradation. Choice B ensures safe and compliant practice by using light-protective measures per labeling and policy. Choice A is incorrect as sunlight accelerates degradation; choice C is suboptimal because freezing is not recommended. Choice D is wrong as high temperatures can cause instability. Use amber bags for light-sensitive IV drugs. A framework is to identify photosensitive agents and incorporate protection into handling protocols.
4. In a hospital oncology ward, a 55-year-old female (70 kg) is receiving cyclophosphamide 1,000 mg IV today; current meds include ondansetron, aprepitant, and normal saline maintenance fluids; allergy: none known. After administration, the nurse asks how to dispose of used tubing, empty IV bags, and PPE due to hazardous drug contamination. How should this medication be disposed of safely?
   Answer: Place contaminated materials (tubing, bags, gloves/gown) into the designated hazardous drug waste stream per facility policy This question tests the pharmacy safety concept of disposing contaminated materials from hazardous drug administration. Cyclophosphamide residues contaminate tubing, bags, and PPE, requiring hazardous waste disposal. Choice B ensures safe and compliant practice by following facility policy and regulations. Choice A is incorrect as residues remain hazardous; choice C is suboptimal because rinsing does not deactivate. Choice D is wrong as chemotherapy is not controlled. Segregate hazardous waste streams. A tip is to train on RCRA rules for P- and U-listed hazardous drugs.
5. In a community pharmacy, a 29-year-old male (90 kg) is prescribed isotretinoin 30 mg PO BID for severe nodular acne; current meds include sertraline 50 mg PO daily and a multivitamin; allergy: none known. The pharmacist needs to manage this medication as a hazardous drug during dispensing and counseling, including preventing exposure to staff who may be pregnant. What is the appropriate handling procedure for this hazardous drug?
   Answer: Handle intact capsules with gloves if exposure risk exists, avoid crushing/opening, and use dedicated equipment if tablets/capsules must be manipulated This question tests the pharmacy safety concept of handling procedures for hazardous drugs with teratogenic potential like isotretinoin. Isotretinoin is hazardous due to severe fetal risks, requiring precautions to avoid manipulation and exposure, especially for pregnant staff. Choice B ensures safe and compliant practice by handling intact, using gloves, and avoiding crushing, per USP <800> and NIOSH guidelines. Choice A is incorrect as opening capsules increases exposure risk; choice C is suboptimal because refrigeration is not needed and segregation alone is insufficient. Choice D is wrong as returns must be disposed as hazardous waste. Counsel patients on proper storage to maintain efficacy. Always evaluate NIOSH classification for appropriate handling of reproductive hazards.
6. In an outpatient rheumatology clinic, a 45-year-old female (68 kg) with rheumatoid arthritis is prescribed methotrexate 15 mg PO once weekly and folic acid 1 mg PO daily. Current medications include ibuprofen 400 mg PO PRN pain; PMH: GERD; allergies: sulfa (hives). The clinic nurse asks what PPE is needed when splitting tablets or handling a dropped tablet during medication administration because methotrexate is a hazardous drug. What personal protective equipment is necessary for administering this drug?
   Answer: Wear chemotherapy-tested gloves when handling tablets; if splitting/crushing is required, add a gown and perform the task in a manner that minimizes dust/aerosolization per policy This question tests appropriate PPE selection when manipulating oral hazardous drugs that may generate dust or particles. Methotrexate is an antimetabolite chemotherapy agent classified as hazardous, requiring protection even at low rheumatologic doses due to its cytotoxic and teratogenic properties. The correct answer (A) specifies chemotherapy-tested gloves for all handling and adds a gown when splitting or crushing tablets, as these activities generate dust that can be inhaled or settle on skin and clothing. Option B incorrectly suggests dose frequency or tablet size affects hazard classification. Option C provides inadequate protection as masks alone don't prevent skin exposure, which is the primary route for tablet handling. Option D incorrectly limits protection to sterile gloves (unnecessary for this purpose) and restricts gown use to IV preparations only. Remember that any manipulation of hazardous drug tablets (splitting, crushing, or cleaning up broken tablets) increases exposure risk and requires additional PPE beyond gloves, and facilities should have dedicated equipment and areas for these activities when possible.
7. In a hospital inpatient unit, a 67-year-old male (80 kg) with acute lymphoblastic leukemia is receiving vincristine 2 mg IV today; current meds include allopurinol 300 mg PO daily, acyclovir 400 mg PO BID, and senna 17.2 mg PO nightly; allergy: none known. A new nurse asks about the safest administration technique to prevent catastrophic errors with vincristine (hazardous). What is the most significant safety consideration for this medication?
   Answer: Dispense and administer vincristine in a minibag (not a syringe) and ensure it is never given intrathecally This question tests the pharmacy safety concept of preventing administration errors with high-risk hazardous drugs like vincristine. Vincristine is a hazardous antineoplastic that is fatal if given intrathecally, necessitating specific safeguards in dispensing and administration. Choice B ensures safe and compliant practice by using minibags and prohibiting intrathecal use, reducing the risk of syringe-based errors per safety guidelines. Choice A is incorrect and dangerous as intrathecal vincristine is contraindicated regardless of platelet count; choice C is suboptimal because room temperature storage is fine, but open bins do not prevent errors. Choice D is wrong as priming should occur with PPE to avoid exposure. Always verify administration route for vinca alkaloids to prevent catastrophic outcomes. A transferable framework is to use forcing functions like minibags for high-alert drugs to enhance safety.
8. In a long-term care facility, a 79-year-old male (70 kg) with chronic pain is on morphine ER 30 mg PO BID and morphine IR 15 mg PO q4h PRN; current meds include senna 17.2 mg PO nightly; allergy: none known. A nurse finds several discontinued morphine tablets in a patient's drawer and asks the pharmacist how to dispose of them per policy to prevent diversion. How should this medication be disposed of safely?
   Answer: Dispose of the tablets using the facility's controlled-substance destruction process with required documentation and witness per regulations This question tests the pharmacy safety concept of controlled substance disposal in facilities to prevent diversion. Morphine tablets require documented destruction with witnesses per regulations. Choice B ensures safe and compliant practice by following policy. Choice A is incorrect as flushing is not preferred; choice C is suboptimal as opioids are not hazardous. Choice D is wrong as restocking is prohibited. Use denaturing kits. A framework is to comply with state and federal disposal rules.
9. In a community pharmacy, a 27-year-old female (58 kg) is prescribed sumatriptan 6 mg/0.5 mL prefilled autoinjector for migraine; current meds include combined oral contraceptive and ibuprofen PRN; allergy: none known. She asks how to store the autoinjectors while traveling and whether they need light protection. Which storage condition is required for this medication?
   Answer: Store at controlled room temperature and protect from extreme temperatures; keep in original packaging if light protection is indicated by labeling This question tests the pharmacy safety concept of temperature and light protection for injectable sumatriptan. Sumatriptan requires room temperature and light protection if specified to prevent degradation. Choice A ensures safe and compliant practice by following labeling. Choice B is incorrect as freezing is not needed; choice C is suboptimal because heat degrades. Choice D is wrong as water exposure ruins it. Monitor for discoloration. A tip is to store in original packaging for light-sensitive injectables.
10. In a community pharmacy, a 52-year-old male (85 kg) is prescribed nitroglycerin sublingual tablets 0.4 mg PRN chest pain; current meds include atorvastatin 40 mg PO nightly and metoprolol succinate 50 mg PO daily; allergy: none known. The patient wants the tablets transferred into a weekly pill organizer for convenience. Which storage condition is required for this medication?
    Answer: Keep tablets in the original tightly closed glass container and protect from moisture/heat; avoid routine transfer to pill organizers This question tests the pharmacy safety concept of moisture and heat protection for sublingual nitroglycerin tablets. Nitroglycerin requires storage in original glass containers to protect from moisture, heat, and volatility. Choice B ensures safe and compliant practice by avoiding transfers that could lead to degradation. Choice A is incorrect as pill organizers expose to moisture; choice C is suboptimal because light protection is secondary. Choice D is wrong as bathroom humidity accelerates breakdown. Counsel on proper storage to preserve potency. Always follow USP standards for hygroscopic or volatile drugs.
11. In a hospital pharmacy, a 59-year-old female (69 kg) is receiving doxorubicin IV (hazardous antineoplastic); current meds include dexamethasone and ondansetron; allergy: none known. After a small spill of doxorubicin on the counter, a technician asks what to do with the absorbent pads and gloves used during cleanup. How should this medication be disposed of safely?
    Answer: Place all contaminated cleanup materials into the designated hazardous drug spill/waste container per facility policy This question tests the pharmacy safety concept of disposing spill cleanup materials for hazardous drugs. Doxorubicin contamination requires hazardous waste disposal of all materials. Choice B ensures safe and compliant practice per USP <800> and policy. Choice A is incorrect as size does not matter; choice C is suboptimal as it is not biohazard. Choice D is wrong as rinsing spreads contamination. Use spill kits properly. A tip is to document spills and train annually.
12. In a community pharmacy, a 45-year-old male (82 kg) is prescribed amoxicillin/clavulanate 875/125 mg PO BID for 7 days; current meds include omeprazole 20 mg PO daily; allergy: none known. The pharmacist dispenses amoxicillin/clavulanate oral suspension for the patient's child in the same visit and is asked about storage requirements after reconstitution. Which storage condition is required for this medication?
    Answer: Store reconstituted suspension in the refrigerator and discard after the labeled beyond-use time This question tests the pharmacy safety concept of storage for reconstituted antibiotic suspensions. Amoxicillin/clavulanate requires refrigeration post-reconstitution to prevent bacterial growth and maintain stability. Choice B ensures safe and compliant practice by adhering to beyond-use dating. Choice A is incorrect as room temperature reduces stability; choice C is suboptimal because freezing damages. Choice D is wrong as light does not inhibit growth. Shake well before use. A tip is to label with storage instructions clearly.
13. In a community pharmacy, a 30-year-old female (58 kg) is prescribed insulin glargine 100 units/mL (U-100) pen: inject 20 units subcutaneously nightly. Current medications include metformin ER 1,000 mg PO daily; PMH: type 2 diabetes; allergies: none. The patient plans to travel and asks how to store the unopened and in-use pens to maintain potency and avoid medication errors. Which storage condition is required for this medication?
    Answer: Unopened pens should be refrigerated; once in use, keep at room temperature and discard after the manufacturer-specified in-use period (e.g., 28 days), avoiding heat and direct light This question tests knowledge of insulin storage requirements to maintain potency and prevent medication errors during travel. Insulin is a protein hormone that denatures when exposed to temperature extremes, losing its glucose-lowering efficacy and potentially leading to hyperglycemic emergencies. The correct answer (A) follows manufacturer guidelines: unopened pens require refrigeration (2-8°C) to maintain potency until expiration date, while in-use pens can be kept at room temperature (below 86°F/30°C) for a specified period (typically 28 days for most insulins) to improve injection comfort, but must be protected from heat and direct sunlight. Option B incorrectly reverses storage requirements and extends in-use dating beyond safe limits. Option C is wrong because freezing permanently damages insulin's protein structure. Option D is dangerous as sunlight and heat rapidly degrade insulin. For travel, advise patients to carry insulin in insulated cases without direct ice contact, never leave it in hot cars, and bring extra supplies with proper documentation for air travel, ensuring continuous access to this life-sustaining medication.
14. In an outpatient hematology clinic, a 72-year-old male (82 kg) with myelodysplastic syndrome is prescribed azacitidine (hazardous antineoplastic) subcutaneous injections for 7 days; current meds include ondansetron 8 mg PO PRN and allopurinol 300 mg PO daily; allergy: none known. The nurse will reconstitute and administer the injection in the clinic. What personal protective equipment is necessary for administering this drug?
    Answer: Chemotherapy-tested gloves and a disposable chemotherapy gown; add eye/face protection if there is risk of splashing or aerosolization during reconstitution This question tests the pharmacy safety concept of PPE for reconstituting and administering hazardous injectables. Azacitidine is hazardous, requiring chemotherapy PPE for handling, including splash protection. Choice B ensures safe and compliant practice by aligning with USP <800> for non-sterile activities. Choice A is incorrect as PPE is always needed; choice C is suboptimal without full protection. Choice D is wrong as gowns are essential. Add respirators if aerosolized. A tip is to tailor PPE to exposure routes.
15. In an outpatient oncology infusion center, a 54-year-old female (70 kg) with breast cancer is starting paclitaxel 175 mg/m² IV every 3 weeks. Current medications include ondansetron 8 mg PO PRN nausea and dexamethasone 8 mg PO premedication; PMH includes hypertension; allergies: penicillin (rash). The pharmacy receives an order to compound paclitaxel IV infusion from a vial labeled as a hazardous drug; the technician asks how to handle and clean up any accidental spill during preparation. What is the appropriate handling procedure for this hazardous drug?
    Answer: Prepare using a closed-system transfer device (CSTD) in an appropriate containment primary engineering control; if spilled, use a hazardous-drug spill kit and dispose of cleanup materials as hazardous waste This question tests knowledge of proper handling procedures for hazardous chemotherapy drugs to ensure healthcare worker safety. Paclitaxel is a cytotoxic chemotherapy agent that requires specialized containment and handling procedures to prevent exposure through inhalation, skin contact, or environmental contamination. The correct answer (B) ensures safe practice by requiring a closed-system transfer device (CSTD) within an appropriate containment primary engineering control (such as a biological safety cabinet or compounding aseptic containment isolator) and proper spill cleanup using a hazardous-drug spill kit with disposal as hazardous waste. Option A is incorrect because open countertop preparation exposes personnel to hazardous drug vapors and alcohol pads are insufficient for decontamination. Option C is dangerous because flushing chemotherapy down the sink contaminates water systems and violates environmental regulations. Option D is incorrect because standard laminar airflow workbenches blow air toward the operator, increasing exposure risk, and bleach alone is not appropriate for chemotherapy spill cleanup. Remember that all hazardous drugs require engineering controls, appropriate PPE, and specialized spill kits to protect healthcare workers and the environment from cytotoxic exposure.
16. In a community pharmacy, a 31-year-old female (64 kg) is prescribed valproic acid delayed-release 500 mg PO BID for bipolar disorder; current meds include quetiapine 200 mg PO nightly; allergy: none known. A staff member who is trying to conceive asks if special handling is needed when counting and packaging valproic acid tablets due to reproductive risk (hazardous). What is the most significant safety consideration for this medication?
    Answer: Minimize occupational exposure (especially for pregnant staff) by avoiding tablet manipulation and using gloves/dedicated equipment if handling could generate residue This question tests the pharmacy safety concept of occupational exposure risks with teratogenic drugs like valproic acid. Valproic acid is hazardous with reproductive risks, requiring minimization of manipulation and PPE. Choice B ensures safe and compliant practice by protecting staff per NIOSH. Choice A is incorrect as it is hazardous; choice C is suboptimal without handling focus. Choice D is wrong as sharps are for needles. Advise alternative duties for pregnant staff. A framework is to use risk assessments for hazardous drugs.
17. In an outpatient oncology clinic, a 63-year-old male (78 kg) with multiple myeloma is starting lenalidomide 25 mg PO daily on days 1–21 of a 28-day cycle; current meds include aspirin 81 mg PO daily and acyclovir 400 mg PO BID; allergy: none known. The clinic pharmacist is training staff on safe handling because lenalidomide is a hazardous, teratogenic agent. What is the appropriate handling procedure for this hazardous drug?
    Answer: Handle capsules intact; do not crush/open; wear gloves when handling if exposure risk exists and clean any contamination per hazardous drug procedures This question tests the pharmacy safety concept of handling intact oral hazardous drugs to minimize exposure. Lenalidomide is hazardous and teratogenic, requiring gloves and no manipulation to avoid residue. Choice B ensures safe and compliant practice by maintaining integrity and cleaning per procedures, per USP <800>. Choice A is incorrect as opening increases exposure; choice C is suboptimal because refrigeration is not required. Choice D is wrong as blowing powder spreads contamination. Restrict handling by pregnant staff. A framework is to use unit-of-use packaging for hazardous orals when possible.
18. In a community pharmacy, a 66-year-old female (74 kg) with hypothyroidism receives a refill of levothyroxine 100 mcg PO daily; current meds include calcium carbonate 500 mg elemental daily and ferrous sulfate 325 mg PO daily; allergy: none known. She asks if she can store all medications in a weekly pill organizer kept in the bathroom. Which storage condition is required for this medication?
    Answer: Store levothyroxine at room temperature in a dry place, protected from moisture and heat; avoid bathroom storage This question tests the pharmacy safety concept of protecting levothyroxine from moisture and heat. Levothyroxine requires dry, room temperature storage to maintain potency. Choice B ensures safe and compliant practice by avoiding bathrooms and organizers that expose it. Choice A is incorrect as humidity degrades it; choice C is suboptimal because freezing is not recommended. Choice D is wrong as sunlight causes degradation. Separate from minerals. A framework is to check stability data for oral solids.
19. At a community pharmacy, a 6-year-old male (20 kg) with type 1 diabetes uses insulin glargine 10 units SC nightly and insulin lispro with meals; allergy: none known. A caregiver asks how to store an in-use insulin glargine pen and unopened backup pens at home to maintain stability. Which storage condition is required for this medication?
    Answer: Store unopened pens refrigerated; store in-use pen at room temperature per product labeling and protect from extreme heat/light This question tests the pharmacy safety concept of proper storage conditions for insulin products to maintain stability and efficacy. Insulin glargine pens require refrigeration for unopened units and room temperature for in-use pens to prevent degradation from temperature extremes. Choice B ensures safe and compliant practice by following manufacturer labeling, protecting from heat and light. Choice A is incorrect as freezing damages insulin; choice C is suboptimal because refrigeration is needed for unopened pens. Choice D is wrong as in-use pens should not be refrigerated. Advise patients to check for particulates before use. A transferable tip is to consult product inserts for specific storage durations and conditions for biologics.
20. In a long-term care facility, an 83-year-old female (54 kg) with atrial fibrillation and recent DVT is prescribed warfarin 5 mg PO daily; current meds include amiodarone 200 mg PO daily, levothyroxine 75 mcg PO daily, and acetaminophen 650 mg PO q6h PRN; allergy: none known. The nurse reports the medication cart contains both heparin 10 units/mL flush syringes and heparin 1,000 units/mL vials stored together. What is the most significant safety consideration for this medication?
    Answer: Segregate and clearly label different heparin concentrations and use barcode scanning to prevent selection errors with this high-alert medication This question tests the pharmacy safety concept of storage and handling precautions for high-alert medications like heparin to prevent selection errors. Heparin is a high-alert anticoagulant with varying concentrations that can lead to dosing errors if not segregated. Choice B ensures safe and compliant practice by segregating concentrations, labeling clearly, and using barcode scanning, aligning with ISMP recommendations for high-alert drugs. Choice A is incorrect as storing together increases error risk; choice C is suboptimal because refrigeration is not required and does not address selection issues. Choice D is wrong as heparin is not hazardous per NIOSH. Segregate high-alert medications to minimize mix-ups. A useful framework is to apply tall man lettering and technology assists for look-alike/sound-alike drugs.

Start this quiz